Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
As a company patent portfolio, Imra Europe SAS currently manages 1 pending office action within the Chemistry & Materials technology area. This matter is assigned to 1 distinct examiner, FERRE, ALEXANDRE F, who is the busiest examiner for the portfolio with 1 pending office action. The prosecution is concentrated within 1 distinct art unit, indicating a specific technical focus for the company's current USPTO activity.
With 1 pending office action and 1 distinct examiner, the prosecution process is highly direct. The involvement of only 1 distinct art unit means there are no conflicting procedural requirements from different examination groups. Practitioners should focus on the specific examination style of FERRE, ALEXANDRE F to resolve the 1 pending office action. This focused structure allows for a clear and efficient approach to the current examination phase, ensuring that all efforts are aligned with the expectations of the examiner involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERRE, ALEXANDRE F | 1 | 59.1% | +20.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691205 | MXene compound having novel crystalline morphology, and process for fabricating a compound of MAX phase type for synthesis of said MXene compound | FERRE, ALEXANDRE F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691205 | MXene compound having novel crystalline morphology, and process for fabricating a compound of MAX phase type for synthesis of said MXene compound | FERRE, ALEXANDRE F | — |
| Art Unit | Apps |
|---|---|
| 1788 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691205 | MXene compound having novel crystalline morphology, and process for fabricating a compound of MAX phase type for synthesis of said MXene compound | FERRE, ALEXANDRE F | 1788 | §102§103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialImra Europe SAS has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alexandre F Ferre has the most, with 1 of Imra Europe SAS's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
